FDA Approved Drugs by Name
Company: Amgen

Search by brand name for drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Each listing contains a brief description of the indication for use. Click on the drug name for a complete product profile, including general information, clinical trial results, side effects and manufacture information.

Blincyto (blinatumomab)

For the treatment of Philadelphia chromosome-negative relapsed /refractory B cell precursor acute lymphoblastic leukemia

Corlanor (ivabradine)

For the treatment of chronic heart failure

Imlygic (talimogene laherparepvec)

For the treatment of unresectable recurrent melanoma

INFERGEN (interferon alfacon-1)

Treatment for chronic hepatitis C virus

Kineret

Injectable therapy for the treatment of rheumatoid arthritis

Neulasta

Treatment to decrease the chance of infection by febrile neutropenia in patients receiving chemotherapy

Neupogen

Treatment for slow white blood cell recovery following chemotherapy

Nplate (romiplostim)

For the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura

Parsabiv (etelcalcetide)

For the treatment of secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis

Prolia (denosumab)

For the treatment of postmenopausal women with osteoporosis at high risk for fracture

Repatha (evolocumab)

For the treatment of high cholesterol

Sensipar (cinacalcet)

For the treatment of secondary hyperparathyroidism and hypercalcemia in parathyroid carcinoma patients

Vectibix (panitumumab)

For the treatment of colorectal cancer

Xgeva (denosumab)

For the prevention of skeletal-related events in patients with bone metastases from solid tumors

Xgeva (denosumab)

For the treatment of giant cell tumor of bone